Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $23

Benzinga Newsdesk www.benzinga.com Neutral 49.3%

Neg 0% Neu 49.3% Pos 0%

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $18 to $23.